Christopher Gleason

Chris Gleason is an experienced leader with a passion for scaling disruptive medical technologies and advancing patient care. With a track record of building talented, high-performing teams, Chris has helped drive adoption of novel devices to standard of care therapies, including creating and growing sizeable businesses at Relievant (acquired by Boston Scientific) and NeoTract (acquired by Teleflex). The MISHA Knee System represents the greatest opportunity yet to change the standard of care for knee osteoarthritis patients.